Mild fibrosis (F0-2) | Severe fibrosis (F3-6) | P value | |
---|---|---|---|
n = 16 | n = 13 | ||
Gender—malea | 9 (56.2) | 8 (61.5) | ns |
Age (years)a | 48.2 ± 14.7 | 54.2 ± 11.6 | ns |
Hbe Ag positivea | – (0) | – (0) | ns |
Anti Hbe Ab positivea | 16 (100) | 13 (100) | – |
HBV DNA (log IU/mL)b | 6.2 ± 5.8 | 8.5 ± 4.7 | ns |
Serum ALT (IU/L)b | 56.5 ± 35.6 | 106.2 ± 87.1 | ns |
Serum AST (IU/L)b | 41.7 ± 29.1 | 75.1 ± 56.1 | 0.01 |
White blood cell count (×109/L)b | 6.2 ± 1.2 | 5.6 ± 1.4 | ns |
Platelet count (×109/L)b | 218.9 ± 52.1 | 177.9 ± 64.54 | ns |
Haemoglobin (g/L)b | 13.8 ± 0.9 | 13.6 ± 1.6 | ns |
Albumin (g/L)b | 4.4 ± 0.3 | 4.4 ± 0.4 | ns |
Prothrombin time (s)b | 11.8 ± 0.8 | 12.1 ± 0.9 | ns |
Direct bilirubin (mg/dL)b | 0.31 ± 0.1 | 0.37 ± 0.1 | ns |
Modified histologic activity indexa | |||
0–4 | 9 (56.25) | 2 (15.3) | |
5–9 | 7 (43.75) | 9 (69.23) | |
10–14 | – | 2 (15.3) | |
15–18 | – | – | |
Fibrosisa | |||
0 | 9 (56.25) | – | |
1 | 2 (12.5) | – | |
2 | 5 (31.25) | – | |
3 | – | 4 (30.7) | |
4 | – | 3 (23.0) | |
5 | – | 4 (30.7) | |
6 | – | 2 (15.3) |